PAI-1-IN-2
PAI-1-IN-2 is a PAI-1 inhibitor with an IC50 of 7.45 μM. By inhibiting PAI-1, PAI-1-IN-2 relieves the inhibitory effect of PAI-1 on tPA and uPA, thereby increasing plasmin levels and promoting fibrinolysis. PAI-1-IN-2 can be used in research related to cardiovascular diseases and cancers.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1190221-46-5
- Formule: C21H17ClN2O6
- Masse moléculaire:428.83
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
IC50 & Target
[1]|
PAI-1 7.45 μM (IC50) |
In Vitro
PAI-1-IN-2 (compound 52) at concentrations of 20-50 μM results in residual PAI-1 activities of 17.7% and 59.2%, respectively, in a cell-free pure enzyme system, with an IC50 value of 7.45 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Parmacokinetics
| Species | Dose | Route | Cmax | Tmax | T1/2 |
|---|---|---|---|---|---|
| Rat[1] | 5 mg/kg | p.o. | 14 μM | 2 h | 2.7 h |
Chemical Information
-
CAS No. 1190221-46-5
-
Masse moléculaire 428.83
-
Formule C21H17ClN2O6
-
SMILES
O=C(O)C1=CC(Cl)=CC=C1NC(=O)COCC(=O)NC2=CC=CC(=C2)C=3OC=CC3
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)